Pharmacology of Parsabiv® (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients

Pharmacology of Parsabiv® (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients

GPCR Target: Ca-sensing

Authors: Kazutsune Harada, et al.

Company: Ono Pharmaceutical Co.

Journal: European Journal of Pharmacology Volume 842, January 5, 2019, 139-145

Year Published: 2019

Tags:

Leave a Reply